SER
Serina Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.55
-0.01 ▼ -0.64%
🌙 3월 13일 7:49 PM ET (한국 3/14 08:49)
$1.52
-0.03 ▼ -1.94%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 49.43% | Shs Outstand | 0.01B | Perf Week | 1.31% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | 12.5% | Insider Trans | -1.99% | Shs Float | 0.01B | Perf Month | -16.67% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | -0.5 | Inst Own | 3.98% | Short Float | 2.39% | Perf Quarter | -51.71% |
| Income | - | P/S | - | EPS this Y | -37.75% | Inst Trans | -1.16% | Short Ratio | 0.09 | Perf Half Y | -69.61% |
| Sales | - | P/B | - | EPS next 5Y | 2.49% | ROA | - | Short Interest | 0.13M | Perf YTD | -18.98% |
| Book/sh | -0.3 | P/C | 1.94 | EPS past 3/5Y | 42.71% 33.3% | ROE | - | 52W High | -80.43% ($7.92) | Perf Year | -62.29% |
| Cash/sh | 0.8 | P/FCF | - | Sales past 3/5Y | 11.87% -49.63% | ROIC | - | 52W Low | 9.15% ($1.42) | Perf 3Y | -93% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 55.34% | Gross Margin | - | Volatility(W/M) | 8.63% 9.24% | Perf 5Y | -97.74% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.19 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.31 | EPS Q/Q | -186.55% | Profit Margin | - | RSI (14) | 37.28 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.31 | Sales Q/Q | -100% | SMA20 | -6.51% ($1.66) | Beta | 1.33 | Target Price | $11 |
| Payout | - | Debt/Eq | 1.82 | Earnings | 11000000 | SMA50 | -29.46% ($2.2) | Rel Volume | 0.03 | Prev Close | $1.56 |
| Employees | 13 | LT Debt/Eq | 0.09 | EPS/Sales Surpr. | 15.09% - | SMA200 | -63.25% ($4.22) | Avg Volume(3M) | 1.38M | Price | $1.55 |
| IPO | 2018/11/29 | Option/Short | No/Yes | Trades | 417 | Volume | 36,496 | Change | -0.64% |
뉴스 로딩 중...